| NCT ID | NCT06639373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | BC Centre on Substance Use |
| Condition | Substance-Related Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-10-05 |
| Primary Completion | 2028-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-10-05 with a primary completion date of 2028-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite substance use causing significant harms and cost to our health care system, British Columbia's (BC) current addiction treatment system remains under-resourced and fragmented. To address this, Providence Health Care (PHC) is expanding clinical addiction services as part of the Road to Recovery Initiative (R2R). The proposed study aims to generate novel data to promote fully evidence-informed and coordinated substance use care in BC and beyond. This study will explore substance use treatment trajectories, identify challenges and areas for growth in addiction health services, characterize important features of patients accessing care, and improve our provincial capacity to promptly tailor approaches to care in response to the substance use crisis.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Able to provide written informed consent * A resident of British Columbia * Willing to comply with study procedures * An individual who has accessed one or more R2R services Exclusion Criteria: * Individuals who have an acute, severe mental health condition (e.g., psychosis) precluding the opportunity to provide full informed consent * Individuals who have an acute, severe medical condition (e.g., intubation) precluding the opportunity to provide full informed consent
Contact & Investigator
Seonaid Nolan, MD, FRCPC
PRINCIPAL INVESTIGATOR
BC Centre on Substance Use
Frequently Asked Questions
Who can join the NCT06639373 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance-Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06639373 currently recruiting?
Yes, NCT06639373 is actively recruiting participants. Contact the research team at seonaid.nolan@bccsu.ubc.ca for enrollment information.
Where is the NCT06639373 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT06639373 clinical trial?
NCT06639373 is sponsored by BC Centre on Substance Use. The principal investigator is Seonaid Nolan, MD, FRCPC at BC Centre on Substance Use. The trial plans to enroll 10,000 participants.